Related Experiment Video

Updated: Apr 24, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

35.4K

Hypoxic ischemic brain injury: Potential therapeutic interventions for the future

Aaron J Muller1, Jeremy D Marks2

  • 1Department of Pediatrics, University of Chicago 900 East 57th Street Chicago IL 60637.

Neoreviews
|September 2, 2014
PubMed

Insights

Perinatal hypoxic-ischemic brain injury (HI) affects neurodevelopment. While hypothermia helps, significant risks remain, prompting research into cellular mechanisms and new treatments for brain protection.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Biomedical Research

Background:

  • Perinatal hypoxic-ischemic brain injury (HI) is a significant cause of adverse neurodevelopmental outcomes in newborns.
  • Therapeutic hypothermia is the current standard of care but does not eliminate the risk of neurological disability.
  • Understanding the cellular mechanisms of neuronal death following HI is crucial for developing improved therapies.

Purpose of the Study:

  • To review the cellular processes underlying brain injury after perinatal HI.
  • To identify potential therapeutic targets and treatments currently under investigation for HI.

Main Methods:

  • Review of basic science research on cellular mechanisms of neuronal death in HI.
  • Analysis of ongoing investigations for novel therapeutic strategies.

Main Results:

  • Cellular research has elucidated key pathways mediating neuronal death post-HI.
  • Several promising therapeutic interventions are being explored for clinical translation.

Conclusions:

  • Despite therapeutic hypothermia, significant neurological morbidity persists after HI.
  • Further research into cellular mechanisms and novel treatments is essential to improve outcomes for affected infants.

Keywords:
F-68allopurinolerythropoietinexcitotoxicitylipid peroxidationmelatoninnitric oxideoxidative stresspoloxamer 188topiramatexenon

More Related Videos

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

888
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

19.1K

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
31
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K